Fran Šaler defended his PhD thesis at the TRIBE doctoral program on August 27, 2025.
Photo: Fran and his supervisor, Prof. Livia Puljak
Thesis title in English: Analysis of methodology, outcomes, and adverse effects in clinical trials of sodium-glucose cotransporter 2 (SGLT2) inhibitors
Thesis title in Croatian: ANALIZA METODOLOGIJE, ISHODA I ŠTETNIH UČINAKA U KLINIČKIM ISTRAŽIVANJIMA INHIBITORA NATRIJ-GLUKOZA KOTRANSPORTERA 2 (SGLT2)
Supervisor: Prof. Livia Puljak, MD, PhD
Full text of the PhD thesis: (TRIBE repository: pdf)
The doctoral thesis is based on the following publications:
•Šaler F, Viđak M, Puljak L. Methodology of clinical trials on sodium-glucose cotransporter 2 inhibitors registered on ClinicalTrials.gov: a cross-sectional study. BMC Med Res Methodol. 2024;24(1):164. IF = 3.4
•Šaler F, Viđak M, Tokalić R, Puljak L. Heterogeneity across outcomes in clinical trials on sodium-glucose cotransporter 2 inhibitors in chronic heart failure: a cross-sectional study. J Clin Epidemiol. 2025;180:111685. IF = 5.2
Enrollment year: 2022
